ASX Announcement

Phase 3 Knee OA Trial Begins, Site Live, Patient Consented

Published: 03/06/25, 08:41am (AEST)3 pages
Paradigm Biopharmaceuticals
PAR:ASXHealthcare

Recent PAR Announcements

Price Sensitive only